Fundraising Fox

Tetraphase Pharmaceuticals

Watertown, US · 5 known investors

Founders & leadership

GM
Guy MacdonaldinCEO2008–2019
LE
Larry EdwardsinExecutive
MSMaria Stahl
Maria StahlinChief Business Officer and General Counsel2015–2020
CW
Christopher WattExecutive

Board

LP
L. Patrick GageBoard director
KM
Keith MaherBoard director
SB
Steven BoydBoard director
JG
John G. FreundBoard director
GH
Gerri HenwoodBoard director
NJ
Nancy J. WysenskiBoard director
GB
Garen BohlinBoard director
JA
Jeffrey A. ChodakewitzBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2020

$10MraisedJan 2020 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • L. Patrick GageDirector
  • Keith MaherDirector
  • Guy MacdonaldDirector
  • Gerri HenwoodDirector
  • Larry EdwardsExecutive Officer, Director
  • Maria StahlExecutive Officer
  • Christopher WattExecutive Officer
  • Nancy J. WysenskiDirector
  • Garen BohlinDirector
  • Steven BoydDirector
  • Jeffrey A. ChodakewitzDirector
  • John G. FreundDirector
Offering amount
$10M
Amount sold
$10M
Sales commissions
$700K
Placement agents
H.C. Wainwright & Co.
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Tetraphase Pharmaceuticals's investors?
Tetraphase Pharmaceuticals's investors include Bay City Capital, F-Prime Capital, Excel Venture Management, Flagship Ventures, Mediphase Venture Partners.
How much funding has Tetraphase Pharmaceuticals raised?
Tetraphase Pharmaceuticals has disclosed $10M raised across 1 round.
Where is Tetraphase Pharmaceuticals headquartered?
Tetraphase Pharmaceuticals is headquartered in Watertown, US.